Trichy Daily

Onychomycosis Market: Industry Analysis, Epidemiology, Symptoms, Treatment, Pipeline Therapies and Key Companies by DelveInsight |Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, etc

 Breaking News
  • No posts were found

Onychomycosis Market: Industry Analysis, Epidemiology, Symptoms, Treatment, Pipeline Therapies and Key Companies by DelveInsight |Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, etc

July 05
19:12 2021
Onychomycosis Market: Industry Analysis, Epidemiology, Symptoms, Treatment, Pipeline Therapies and Key Companies by DelveInsight |Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, etc

Onychomycosis Market

DelveInsight’s Onychomycosis Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options. 

The report also offers comprehensive insights into Onychomycosis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market size forward in the 7MM [US, EU5(Germany, France, the United Kingdom, Spain, and Italy) and Japan].

 

Some of the key highlights from the Onychomycosis Market Insights: 

  • As per Delveinsight, Onychomycosis Market was estimated to be USD 3842.6 million in 2017.
  • In 2017, Onychomycosis’s prevalent population in the United States was found to be 35,829,110.
  • Spain reported the least number of prevalent cases in the 7MM.
  • As per Delveinsight’s estimates, the total prevalent cases for Onychomycosis were highest in the United States, followed by Japan & France.
  • MOB-015 (Moberg Pharma), which is expected to launch during the forecast period (2020–2030), is anticipated to be the most promising therapy amongst all the other desired drug candidates.
  • According to DelveInsight’s analysis, no gender bias was observed in the case of Onychomycosis.

 

 

Request for free Sample Page: https://www.delveinsight.com/sample-request/onychomycosis-market

 

Onychomycosis Disease Overview:

Onychomycosis, the most common fungal nail infection that has been evaluated to account for about half of all nail diseases. It causes discoloration and thickening of the affected nail. Onychomycosis was initially believed to be caused predominantly by dermatophytes; however, new studies have unveiled that mixed infections & those caused by nondermatophyte molds are more prevalent than previously thought, especially in warmer climates.

Although not life-threatening, fungal nail infections are significant public health concerns due to their high prevalence, inadequate response to therapy & significant clinical, social and financial impact.

 

Onychomycosis Symptoms:

Symptoms include yellow or white nail discoloration, separation of the nail from the nail bed, thickening of the nail, Dry or scaly skin around the nail, Foul smell, Etc.

 

Request for free Sample Page: https://www.delveinsight.com/sample-request/onychomycosis-market

 

Onychomycosis Epidemiology Segmentation 

The Onychomycosis Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Onychomycosis Prevalence 
  • Severity Specific Onychomycosis Prevalence 
  • Diagnosed and Treatable Cases of Onychomycosis

 

 

Onychomycosis Pipeline Therapies and Key Companies 

  • Moberg Pharma: MOB-015
  • Blueberry Therapeutics: BB2603
  • Mycovia Pharmaceuticals: VT-1161
  • Bausch Health: Jublia//Clenafin (efinaconazole)
  • Pfizer: Kerydin (tavaborole)
  • Sato Pharmaceutical/Bausch Health: Luliconazole
  • Sato Pharmaceutical/ Eisai: Nialin
  • Meiji Seika Pharma: ME111 
  • NovaBiotics: NP213 (Novexatin)
  • Halllux: HTS-519
  • And Many Others

 

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Onychomycosis, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Onychomycosis epidemiology and treatment in the 7MM
  • Current and emerging therapies for Onychomycosis
  • Onychomycosis market drivers and barriers 

 

Table of Contents 

1

Key Insights

2

Report Introduction

3

Competitive Intelligence Analysis for Onychomycosis

4

Onychomycosis Market Overview at a Glance

5

Executive Summary of Onychomycosis

6

Onychomycosis Epidemiology and Market Methodology

7

Onychomycosis Epidemiology and Patient Population

8

Onychomycosis Patient Journey

9

Treatment Algorithm, Current Treatment, and Medical Practices

10

Key Endpoints in Onychomycosis Clinical Trials

11

Onychomycosis Marketed Therapies 

12

Onychomycosis Emerging Therapies

13

Onychomycosis: 7 Major Market Analysis

14

Attribute analysis

15

Access and Reimbursement Overview of Onychomycosis

16

KOL Reviews

17

Case Reports

18

Onychomycosis Market Drivers

19

Onychomycosis Market Barriers

20

SWOT Analysis

21

Disclaimer

21

DelveInsight Capabilities

22

About DelveInsight

 

Learn more about the report offerings @ https://www.delveinsight.com/sample-request/onychomycosis-market

 

About DelveInsight 

DelveInsight is a leading Market Research & Business Consultant focused purely on life sciences. It helps pharma companies by providing them with end-to-end services to boost their performance.

Get access to all the Pharma & healthcare market research reports through our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/onychomycosis-market

Related Articles